ResearcherUniversity of Southern CaliforniaNo recent work listed

Philipp C. Manegold

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0722-7043; OpenAlex author ID A5046604149. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper

Papers 1

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer. Co-author DOI 10.3390/cancers10040095 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuri Genyk · 1 shared paper, 2018 · strength 0.07
- Paper Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer. DOI 10.3390/cancers10040095 ↗
Heinz‐Josef Lenz · 1 shared paper, 2018 · strength 0.07
- Paper Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer. DOI 10.3390/cancers10040095 ↗
Stephen Jacob Pandol · 1 shared paper, 2018 · strength 0.07
- Paper Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer. DOI 10.3390/cancers10040095 ↗
Michaël Kahn · 1 shared paper, 2018 · strength 0.07
- Paper Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer. DOI 10.3390/cancers10040095 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.